Authors: Chekhun, VF Todor, IN Solyanik, GI Kulik, GI Tryndiak, VP

Citation: Vf. Chekhun et al., Oxidative phosphorylation and energy status in doxorubicin-sensitive and doxorubicin-resistant Guerin carcinoma, EXP ONCOL, 22(4), 2000, pp. 195-199

Authors: Lukyanova, NY Kulik, GI Yurchenko, OV Shatrova, KM Vorobyova, LI Svintitsky, VS Evtushenko, GV Chekhun, VF

Citation: Ny. Lukyanova et al., Expression of p53 and Bcl-2 proteins in epithelial ovarian carcinoma with different grade of differentiation, EXP ONCOL, 22(1-2), 2000, pp. 91-93

Authors: Solyanik, GI Todor, IN Kulik, GI Chekhun, VF

Citation: Gi. Solyanik et al., Selective mechanism of the emergence of Guerin's carcinoma resistance to doxorubicin, EXP ONCOL, 21(3-4), 1999, pp. 264-268

Authors: Kulik, GI

Citation: Gi. Kulik, Comparative in vitro study of the effects of the new antitumor drug Ukrainand several cytostatic agents on the thiol groups in the tissue of Guerin carcinoma and its resistance to cisplatin variant, DRUG EXP CL, 24(5-6), 1998, pp. 277-280

Authors: Kulik, GI Deneka, ER Todor, IN Karmozina, LG

Citation: Gi. Kulik et al., Study of acute toxicity of Ukrain in rats after intravenous injection, DRUG EXP CL, 24(5-6), 1998, pp. 287-293

Authors: Chekhun, VF Shishova, YV Yurchenko, OV Shlapatskaya, LN Mikhalap, SV Berdova, AG Sidorenko, SP Kulik, GI Gluzman, DF

Citation: Vf. Chekhun et al., Synergistic cytotoxic effect of cisplatin and monoclonal anti-Fas IPO-4 antibodies on human epidermoid carcinoma cell line KB, EXP ONCOL, 20(3-4), 1998, pp. 210-216